Cancer Medicine·Nov 3Renin–Angiotensin System Inhibitor Use and Cancer Incidence Among UK Biobank Participants: A Prospective Cohort StudyCohort study of 94,696 peopleCancerPaper
Frontiers in Oncology·Oct 30A 20 years Follow-up Results of the Modena Screening Program for Prostate Cancer (PCa) "Progetto Uomo"(PU)Accepted, not yet published: cohort study of 39,840 peopleProstate cancer screeningPaper
Cancer Causes & Control·Aug 19Global burden of prostate cancer (1990-2021) from Brazil: trends in disability-adjusted life years, incidence, mortality, and prevalenceComputational studyProstate cancerPaper
Frontiers in Nutrition·Aug 13Dietary spermidine intake is not associated with prostate cancer incidence or prostate cancer-specific mortality: findings from the prostate, lung, colorectal, and ovarian cancer screening trialCohort study of 54,517 peopleProstate cancerPaper
BJU International·Feb 18The 5-year outcomes of a regional population-based PSA information and testing programmeCohort study of 44,530 peopleInterventionsPaper
JAMA Network Open·Feb 2Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 YearsCohort study of 2,651 peopleProstate cancerPaper
JNCI Cancer Spectrum·Oct 23Age-specific racial disparities in the incidence of fatal prostate cancer: an analytic deconstructionCohort study in peopleProstate cancerPaper
British Journal of Cancer·Apr 30Clinical biomarker-based biological aging and risk of cancer in the UK BiobankCohort study of 308,156 peopleCancerPaper
Cancer Epidemiology·Jan 14Trends in Prostate Specific Antigen (PSA) testing and prostate cancer incidence and mortality in Australia: A critical analysisCohort study in peopleProstate cancerPaper
CMAJ Open·Jun 10Trends in prostate cancer incidence and mortality in Canada during the era of prostate-specific antigen screeningStudy in peopleProstate cancerPaper